Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Emtricitabin + Rilpivirin + Tenofovir disoproxil fumarat, ATC J05AR08 f. d. Z. 01.09.24 - 31.08.26
- Buyer
- DAK-Gesundheit
- Winners
- Abacus Medicine A/S, axicorp Pharma B.V., CC Pharma GmbH, EMRA-MED Arzneimittel GmbH, EurimPharm Arzneimittel GmbH, kohlpharma GmbH, Medicopharm AG, Originalis B.V.
- Contract value
- no value published
- Bids received
- 9
- Published
- 2 Sept 2026
- Awarded
- 1 Sept 2024
- Contract start
- 1 Sept 2024
- Region
- Hamburg (DE600)